Humira generic availability, cost, and dosage
The Checkup by Singlecare
MARCH 8, 2024
Hadlima (adalimumab-bwwd) Hadlima was the fourth Humira biosimilar, approved in July 2019 and available in the United States as of July 2023. It was approved in November 2019 as a biosimilar and approved as an interchangeable biosimilar in October 2023. The pharmaceutical company that makes Hadlima is called Organon.
Let's personalize your content